AEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%

61
25
Favorite

AEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%

investorplace2021-06-10

Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus. Aethlon Medical shared...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（25）

eo1668
·2021-06-24
please help like and comment.[微笑]
Reply
Like
Report
中国ChinaATM
·2021-06-10
Alibaba, Tencent and Meituan are all undervalued now. Grab them now.Please like and comment 'CHINA ATM TO THE MOON'!!
Reply
Like
Report
may_bb
·2021-06-10
[微笑]
Reply
Like
Report
HKhin
·2021-06-10
Up n down up n down
Reply
Like
Report
CGE
·2021-06-10
Ok
Reply
Like
Report
Kelowee
·2021-06-10
Like comment ?
Reply
2
Report
Fold Replies
- GraceChan:
  ok
  2021-06-10
  Reply
  Report
Thomas9413
·2021-06-10
Please comment .. thanks
Reply
1
Report
Fold Replies
- tearach:
  pls like
  2021-06-10
  Reply
  Report
- CGE:
  ok
  2021-06-10
  Reply
  Report
KK2021
·2021-06-10
Pls like and comment
Reply
2
Report
Fold Replies
- KK2021:
  woww
  2021-06-11
  Reply
  Report
- KK2021:
  ok
  2021-06-10
  Reply
  Report
- arachno73:
  Like and comment back plew. Thanks.
  2021-06-10
  Reply
  Report
View more 1 comments
e13v3n
·2021-06-10
pls like n comment
Reply
2
Report
Fold Replies
- tearach:
  pls comment
  2021-06-10
  Reply
  Report
Racheltestin
·2021-06-10
Like and comment pls!
Reply
2
Report
Fold Replies
- tearach:
  pls like
  2021-06-10
  Reply
  Report
Ash1285
·2021-06-10
Wow..pls like and comment thanks
Reply
3
Report
Fold Replies
- tearach:
  pls comment
  2021-06-10
  Reply
  Report
- e13v3n:
  pl reply
  2021-06-10
  Reply
  Report
- Ash1285:
  thanks
  2021-06-10
  Reply
  Report
TraderGw
·2021-06-10
Like and comment
Reply
2
Report
Fold Replies
- Ash1285:
  Yes
  2021-06-10
  Reply
  Report
许哲东
·2021-06-10
Another AMC stock with no limit rising..like and comment please
Reply
2
Report
Fold Replies
- e13v3n:
  pl reply
  2021-06-10
  Reply
  Report
Kevin92
·2021-06-10
Like and commnet
Reply
1
Report
Fold Replies
- Ash1285:
  Yes
  2021-06-10
  Reply
  Report
AJAJ
·2021-06-10
Pls like and comment
Reply
Like
Report
Fold Replies
- Kevin92:
  Like and commnet
  2021-06-10
  Reply
  Report
kksuen
·2021-06-10
Comment and like pls
Reply
2
Report
Fold Replies
- AJAJ:
  Ok
  2021-06-10
  Reply
  Report
- milliongal:
  ok
  2021-06-10
  Reply
  Report
- AJAJ:
  Ok pls reply
  2021-06-10
  Reply
  Report
View more 1 comments
milliongal
·2021-06-10
Ok
Reply
1
Report
Nn9876543
·2021-06-10
Pls like n comment
Reply
1
Report
Fold Replies
- kksuen:
  ok
  2021-06-10
  Reply
  Report
SheldonK
·2021-06-10
Nice！
Reply
Like
Report
crisis
·2021-06-10
Amazing
Reply
Like
Report
Fold Replies
- knn:
  comment my comment pl
  2021-06-10
  Reply
  Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1168166668?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-06-10 07:29","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1168166668","market":"us","top_or_hot":-1,"title":"AEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%","media":"investorplace","content":"<div>\n<p>Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.\nAethlon Medical shared...</p>\n\n<a href=\"https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/\">Source Link</a>\n\n</div>\n","source":"lsy1606302653667","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-10 07:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.\nAethlon Medical shared...</p>\n\n<a href=\"https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AEMD","symbol_name":"Aethlon Medical Inc","start_time":0,"source_url":"https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/","article_id":"1168166668","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1168166668","pubTimestamp":1623281394,"columns":[],"sourceInfo":{"source_id":"lsy1606302653667","name":"InvestorPlace"},"weMediaInfo":null,"summary":"Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged ","collect":0,"end_time":0,"defaultTopTitle":"investorplace.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"AEMD":"Aethlon Medical Inc"},"translate_title":"AEMD股票：历史性的Covid-19消息推动Aethlon Medical暴涨388%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AEMD":0.9},"content_text":"Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.\nAethlon Medical shared results last Thursday fortwo patients with Covid-19that were treated with the company’s Hemopurifier. According to the release, this is “a cartridge that is designed to filter viruses and exosomes from the blood.” In turn, the patients were treated over a total of nine sessions, and both showed improvements in their condition.\nMoreover, the Hemopurifier is designated as a“Breakthrough Device”by the U.S. Food and Drug Administration (FDA) for treating metastatic cancer. Now, the tool is now closely being looked at by the FDA through an early feasibility study.\nCharles J. Fisher, Jr., CEO of Aethlon Medical, said this about the AEMD stock news.\n\n “The COVID-19 pandemic has affected the world over, prompting the need for innovative treatment approaches. We believe that the Hemopurifier® is such an innovation, as it is the only known device that can filter out exosomes, which are thought to play a role in the severity of infectious diseases like COVID-19. … These two case studies indicate that the Hemopurifier® was successfully able to clear SARS-CoV-2 virus and associated exosomes from the blood stream, resulting in a potential benefit for one of the critical COVID-19 patients that were treated.”\n\nAEMD stock was up 388% as of Wednesday afternoon.","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":128005664,"gmtCreate":1624494477058,"gmtModify":1703838206624,"author":{"id":"3560376076037644","authorId":"3560376076037644","name":"eo1668","avatar":"https://static.tigerbbs.com/039a625a00fac8daa05bb87ff64ecd3c","vip":1,"crmLevel":6,"crmLevelSwitch":1,"idStr":"3560376076037644","authorIdStr":"3560376076037644"},"htmlText":"please help like and comment.[微笑]&nbsp;","listText":"please help like and comment.[微笑]&nbsp;","text":"please help like and comment.[微笑]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/128005664","repostId":1168166668,"repostType":2,"repost":{"id":"1168166668","kind":"news","pubTimestamp":1623281394,"share":"https://ttm.financial/m/news/1168166668?lang=&edition=fundamental","pubTime":"2021-06-10 07:29","market":"us","language":"en","title":"AEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%","url":"https://stock-news.laohu8.com/highlight/detail?id=1168166668","media":"investorplace","summary":"Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged ","content":"<p>Shares of&nbsp;<b>Aethlon Medical</b>(NASDAQ:<b><u>AEMD</u></b>) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.</p>\n<p>Aethlon Medical shared results last Thursday fortwo patients with Covid-19that were treated with the company’s Hemopurifier. According to the release, this is “a cartridge that is designed to filter viruses and exosomes from the blood.” In turn, the patients were treated over a total of nine sessions, and both showed improvements in their condition.</p>\n<p>Moreover, the Hemopurifier is designated as a“Breakthrough Device”by the U.S. Food and Drug Administration (FDA) for treating metastatic cancer. Now, the tool is now closely being looked at by the FDA through an early feasibility study.</p>\n<p>Charles J. Fisher, Jr., CEO of Aethlon Medical, said this about the AEMD stock news.</p>\n<blockquote>\n “The COVID-19 pandemic has affected the world over, prompting the need for innovative treatment approaches. We believe that the Hemopurifier® is such an innovation, as it is the only known device that can filter out exosomes, which are thought to play a role in the severity of infectious diseases like COVID-19. … These two case studies indicate that the Hemopurifier® was successfully able to clear SARS-CoV-2 virus and associated exosomes from the blood stream, resulting in a potential benefit for one of the critical COVID-19 patients that were treated.”\n</blockquote>\n<p>AEMD stock was up&nbsp;388% as of Wednesday afternoon.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-10 07:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.\nAethlon Medical shared...</p>\n\n<a href=\"https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AEMD":"Aethlon Medical Inc"},"source_url":"https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168166668","content_text":"Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.\nAethlon Medical shared results last Thursday fortwo patients with Covid-19that were treated with the company’s Hemopurifier. According to the release, this is “a cartridge that is designed to filter viruses and exosomes from the blood.” In turn, the patients were treated over a total of nine sessions, and both showed improvements in their condition.\nMoreover, the Hemopurifier is designated as a“Breakthrough Device”by the U.S. Food and Drug Administration (FDA) for treating metastatic cancer. Now, the tool is now closely being looked at by the FDA through an early feasibility study.\nCharles J. Fisher, Jr., CEO of Aethlon Medical, said this about the AEMD stock news.\n\n “The COVID-19 pandemic has affected the world over, prompting the need for innovative treatment approaches. We believe that the Hemopurifier® is such an innovation, as it is the only known device that can filter out exosomes, which are thought to play a role in the severity of infectious diseases like COVID-19. … These two case studies indicate that the Hemopurifier® was successfully able to clear SARS-CoV-2 virus and associated exosomes from the blood stream, resulting in a potential benefit for one of the critical COVID-19 patients that were treated.”\n\nAEMD stock was up 388% as of Wednesday afternoon.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":183028616,"gmtCreate":1623295099435,"gmtModify":1704200298744,"author":{"id":"3584867430360256","authorId":"3584867430360256","name":"中国ChinaATM","avatar":"https://static.tigerbbs.com/bd214125064b4d25501bb48cef2fb529","vip":1,"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":5,"crmLevelSwitch":0,"idStr":"3584867430360256","authorIdStr":"3584867430360256"},"htmlText":"Alibaba, Tencent and Meituan are all undervalued now. Grab them now.Please like and comment 'CHINA ATM TO THE MOON'!!","listText":"Alibaba, Tencent and Meituan are all undervalued now. Grab them now.Please like and comment 'CHINA ATM TO THE MOON'!!","text":"Alibaba, Tencent and Meituan are all undervalued now. Grab them now.Please like and comment 'CHINA ATM TO THE MOON'!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/183028616","repostId":1168166668,"repostType":4,"repost":{"id":"1168166668","kind":"news","pubTimestamp":1623281394,"share":"https://ttm.financial/m/news/1168166668?lang=&edition=fundamental","pubTime":"2021-06-10 07:29","market":"us","language":"en","title":"AEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%","url":"https://stock-news.laohu8.com/highlight/detail?id=1168166668","media":"investorplace","summary":"Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged ","content":"<p>Shares of&nbsp;<b>Aethlon Medical</b>(NASDAQ:<b><u>AEMD</u></b>) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.</p>\n<p>Aethlon Medical shared results last Thursday fortwo patients with Covid-19that were treated with the company’s Hemopurifier. According to the release, this is “a cartridge that is designed to filter viruses and exosomes from the blood.” In turn, the patients were treated over a total of nine sessions, and both showed improvements in their condition.</p>\n<p>Moreover, the Hemopurifier is designated as a“Breakthrough Device”by the U.S. Food and Drug Administration (FDA) for treating metastatic cancer. Now, the tool is now closely being looked at by the FDA through an early feasibility study.</p>\n<p>Charles J. Fisher, Jr., CEO of Aethlon Medical, said this about the AEMD stock news.</p>\n<blockquote>\n “The COVID-19 pandemic has affected the world over, prompting the need for innovative treatment approaches. We believe that the Hemopurifier® is such an innovation, as it is the only known device that can filter out exosomes, which are thought to play a role in the severity of infectious diseases like COVID-19. … These two case studies indicate that the Hemopurifier® was successfully able to clear SARS-CoV-2 virus and associated exosomes from the blood stream, resulting in a potential benefit for one of the critical COVID-19 patients that were treated.”\n</blockquote>\n<p>AEMD stock was up&nbsp;388% as of Wednesday afternoon.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-10 07:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.\nAethlon Medical shared...</p>\n\n<a href=\"https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AEMD":"Aethlon Medical Inc"},"source_url":"https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168166668","content_text":"Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.\nAethlon Medical shared results last Thursday fortwo patients with Covid-19that were treated with the company’s Hemopurifier. According to the release, this is “a cartridge that is designed to filter viruses and exosomes from the blood.” In turn, the patients were treated over a total of nine sessions, and both showed improvements in their condition.\nMoreover, the Hemopurifier is designated as a“Breakthrough Device”by the U.S. Food and Drug Administration (FDA) for treating metastatic cancer. Now, the tool is now closely being looked at by the FDA through an early feasibility study.\nCharles J. Fisher, Jr., CEO of Aethlon Medical, said this about the AEMD stock news.\n\n “The COVID-19 pandemic has affected the world over, prompting the need for innovative treatment approaches. We believe that the Hemopurifier® is such an innovation, as it is the only known device that can filter out exosomes, which are thought to play a role in the severity of infectious diseases like COVID-19. … These two case studies indicate that the Hemopurifier® was successfully able to clear SARS-CoV-2 virus and associated exosomes from the blood stream, resulting in a potential benefit for one of the critical COVID-19 patients that were treated.”\n\nAEMD stock was up 388% as of Wednesday afternoon.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":189797102,"gmtCreate":1623287968006,"gmtModify":1704200095159,"author":{"id":"3581758336143094","authorId":"3581758336143094","name":"may_bb","avatar":"https://static.tigerbbs.com/d7bdcb7e740e6a76cca3ed15f2bc52b4","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3581758336143094","authorIdStr":"3581758336143094"},"htmlText":"[微笑]&nbsp;","listText":"[微笑]&nbsp;","text":"[微笑]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/189797102","repostId":1168166668,"repostType":4,"repost":{"id":"1168166668","kind":"news","pubTimestamp":1623281394,"share":"https://ttm.financial/m/news/1168166668?lang=&edition=fundamental","pubTime":"2021-06-10 07:29","market":"us","language":"en","title":"AEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%","url":"https://stock-news.laohu8.com/highlight/detail?id=1168166668","media":"investorplace","summary":"Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged ","content":"<p>Shares of&nbsp;<b>Aethlon Medical</b>(NASDAQ:<b><u>AEMD</u></b>) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.</p>\n<p>Aethlon Medical shared results last Thursday fortwo patients with Covid-19that were treated with the company’s Hemopurifier. According to the release, this is “a cartridge that is designed to filter viruses and exosomes from the blood.” In turn, the patients were treated over a total of nine sessions, and both showed improvements in their condition.</p>\n<p>Moreover, the Hemopurifier is designated as a“Breakthrough Device”by the U.S. Food and Drug Administration (FDA) for treating metastatic cancer. Now, the tool is now closely being looked at by the FDA through an early feasibility study.</p>\n<p>Charles J. Fisher, Jr., CEO of Aethlon Medical, said this about the AEMD stock news.</p>\n<blockquote>\n “The COVID-19 pandemic has affected the world over, prompting the need for innovative treatment approaches. We believe that the Hemopurifier® is such an innovation, as it is the only known device that can filter out exosomes, which are thought to play a role in the severity of infectious diseases like COVID-19. … These two case studies indicate that the Hemopurifier® was successfully able to clear SARS-CoV-2 virus and associated exosomes from the blood stream, resulting in a potential benefit for one of the critical COVID-19 patients that were treated.”\n</blockquote>\n<p>AEMD stock was up&nbsp;388% as of Wednesday afternoon.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-10 07:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.\nAethlon Medical shared...</p>\n\n<a href=\"https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AEMD":"Aethlon Medical Inc"},"source_url":"https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168166668","content_text":"Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.\nAethlon Medical shared results last Thursday fortwo patients with Covid-19that were treated with the company’s Hemopurifier. According to the release, this is “a cartridge that is designed to filter viruses and exosomes from the blood.” In turn, the patients were treated over a total of nine sessions, and both showed improvements in their condition.\nMoreover, the Hemopurifier is designated as a“Breakthrough Device”by the U.S. Food and Drug Administration (FDA) for treating metastatic cancer. Now, the tool is now closely being looked at by the FDA through an early feasibility study.\nCharles J. Fisher, Jr., CEO of Aethlon Medical, said this about the AEMD stock news.\n\n “The COVID-19 pandemic has affected the world over, prompting the need for innovative treatment approaches. We believe that the Hemopurifier® is such an innovation, as it is the only known device that can filter out exosomes, which are thought to play a role in the severity of infectious diseases like COVID-19. … These two case studies indicate that the Hemopurifier® was successfully able to clear SARS-CoV-2 virus and associated exosomes from the blood stream, resulting in a potential benefit for one of the critical COVID-19 patients that were treated.”\n\nAEMD stock was up 388% as of Wednesday afternoon.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":189498844,"gmtCreate":1623284216188,"gmtModify":1704199952038,"author":{"id":"3571009840536733","authorId":"3571009840536733","name":"HKhin","avatar":"https://static.tigerbbs.com/315ef1291b235114bbffd11981704437","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3571009840536733","authorIdStr":"3571009840536733"},"htmlText":"Up n down up n down","listText":"Up n down up n down","text":"Up n down up n down","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/189498844","repostId":1168166668,"repostType":4,"repost":{"id":"1168166668","kind":"news","pubTimestamp":1623281394,"share":"https://ttm.financial/m/news/1168166668?lang=&edition=fundamental","pubTime":"2021-06-10 07:29","market":"us","language":"en","title":"AEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%","url":"https://stock-news.laohu8.com/highlight/detail?id=1168166668","media":"investorplace","summary":"Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged ","content":"<p>Shares of&nbsp;<b>Aethlon Medical</b>(NASDAQ:<b><u>AEMD</u></b>) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.</p>\n<p>Aethlon Medical shared results last Thursday fortwo patients with Covid-19that were treated with the company’s Hemopurifier. According to the release, this is “a cartridge that is designed to filter viruses and exosomes from the blood.” In turn, the patients were treated over a total of nine sessions, and both showed improvements in their condition.</p>\n<p>Moreover, the Hemopurifier is designated as a“Breakthrough Device”by the U.S. Food and Drug Administration (FDA) for treating metastatic cancer. Now, the tool is now closely being looked at by the FDA through an early feasibility study.</p>\n<p>Charles J. Fisher, Jr., CEO of Aethlon Medical, said this about the AEMD stock news.</p>\n<blockquote>\n “The COVID-19 pandemic has affected the world over, prompting the need for innovative treatment approaches. We believe that the Hemopurifier® is such an innovation, as it is the only known device that can filter out exosomes, which are thought to play a role in the severity of infectious diseases like COVID-19. … These two case studies indicate that the Hemopurifier® was successfully able to clear SARS-CoV-2 virus and associated exosomes from the blood stream, resulting in a potential benefit for one of the critical COVID-19 patients that were treated.”\n</blockquote>\n<p>AEMD stock was up&nbsp;388% as of Wednesday afternoon.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-10 07:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.\nAethlon Medical shared...</p>\n\n<a href=\"https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AEMD":"Aethlon Medical Inc"},"source_url":"https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168166668","content_text":"Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.\nAethlon Medical shared results last Thursday fortwo patients with Covid-19that were treated with the company’s Hemopurifier. According to the release, this is “a cartridge that is designed to filter viruses and exosomes from the blood.” In turn, the patients were treated over a total of nine sessions, and both showed improvements in their condition.\nMoreover, the Hemopurifier is designated as a“Breakthrough Device”by the U.S. Food and Drug Administration (FDA) for treating metastatic cancer. Now, the tool is now closely being looked at by the FDA through an early feasibility study.\nCharles J. Fisher, Jr., CEO of Aethlon Medical, said this about the AEMD stock news.\n\n “The COVID-19 pandemic has affected the world over, prompting the need for innovative treatment approaches. We believe that the Hemopurifier® is such an innovation, as it is the only known device that can filter out exosomes, which are thought to play a role in the severity of infectious diseases like COVID-19. … These two case studies indicate that the Hemopurifier® was successfully able to clear SARS-CoV-2 virus and associated exosomes from the blood stream, resulting in a potential benefit for one of the critical COVID-19 patients that were treated.”\n\nAEMD stock was up 388% as of Wednesday afternoon.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":189406097,"gmtCreate":1623283874819,"gmtModify":1704199940096,"author":{"id":"3584000899703971","authorId":"3584000899703971","name":"CGE","avatar":"https://static.tigerbbs.com/b8e167178f9d1ac99fa1763f8545f998","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3584000899703971","authorIdStr":"3584000899703971"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/189406097","repostId":1168166668,"repostType":4,"repost":{"id":"1168166668","kind":"news","pubTimestamp":1623281394,"share":"https://ttm.financial/m/news/1168166668?lang=&edition=fundamental","pubTime":"2021-06-10 07:29","market":"us","language":"en","title":"AEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%","url":"https://stock-news.laohu8.com/highlight/detail?id=1168166668","media":"investorplace","summary":"Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged ","content":"<p>Shares of&nbsp;<b>Aethlon Medical</b>(NASDAQ:<b><u>AEMD</u></b>) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.</p>\n<p>Aethlon Medical shared results last Thursday fortwo patients with Covid-19that were treated with the company’s Hemopurifier. According to the release, this is “a cartridge that is designed to filter viruses and exosomes from the blood.” In turn, the patients were treated over a total of nine sessions, and both showed improvements in their condition.</p>\n<p>Moreover, the Hemopurifier is designated as a“Breakthrough Device”by the U.S. Food and Drug Administration (FDA) for treating metastatic cancer. Now, the tool is now closely being looked at by the FDA through an early feasibility study.</p>\n<p>Charles J. Fisher, Jr., CEO of Aethlon Medical, said this about the AEMD stock news.</p>\n<blockquote>\n “The COVID-19 pandemic has affected the world over, prompting the need for innovative treatment approaches. We believe that the Hemopurifier® is such an innovation, as it is the only known device that can filter out exosomes, which are thought to play a role in the severity of infectious diseases like COVID-19. … These two case studies indicate that the Hemopurifier® was successfully able to clear SARS-CoV-2 virus and associated exosomes from the blood stream, resulting in a potential benefit for one of the critical COVID-19 patients that were treated.”\n</blockquote>\n<p>AEMD stock was up&nbsp;388% as of Wednesday afternoon.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-10 07:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.\nAethlon Medical shared...</p>\n\n<a href=\"https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AEMD":"Aethlon Medical Inc"},"source_url":"https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168166668","content_text":"Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.\nAethlon Medical shared results last Thursday fortwo patients with Covid-19that were treated with the company’s Hemopurifier. According to the release, this is “a cartridge that is designed to filter viruses and exosomes from the blood.” In turn, the patients were treated over a total of nine sessions, and both showed improvements in their condition.\nMoreover, the Hemopurifier is designated as a“Breakthrough Device”by the U.S. Food and Drug Administration (FDA) for treating metastatic cancer. Now, the tool is now closely being looked at by the FDA through an early feasibility study.\nCharles J. Fisher, Jr., CEO of Aethlon Medical, said this about the AEMD stock news.\n\n “The COVID-19 pandemic has affected the world over, prompting the need for innovative treatment approaches. We believe that the Hemopurifier® is such an innovation, as it is the only known device that can filter out exosomes, which are thought to play a role in the severity of infectious diseases like COVID-19. … These two case studies indicate that the Hemopurifier® was successfully able to clear SARS-CoV-2 virus and associated exosomes from the blood stream, resulting in a potential benefit for one of the critical COVID-19 patients that were treated.”\n\nAEMD stock was up 388% as of Wednesday afternoon.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":189552812,"gmtCreate":1623282893636,"gmtModify":1704199904703,"author":{"id":"3579871664787622","authorId":"3579871664787622","name":"Kelowee","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3579871664787622","authorIdStr":"3579871664787622"},"htmlText":"Like comment ?","listText":"Like comment ?","text":"Like comment ?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/189552812","repostId":1168166668,"repostType":4,"repost":{"id":"1168166668","kind":"news","pubTimestamp":1623281394,"share":"https://ttm.financial/m/news/1168166668?lang=&edition=fundamental","pubTime":"2021-06-10 07:29","market":"us","language":"en","title":"AEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%","url":"https://stock-news.laohu8.com/highlight/detail?id=1168166668","media":"investorplace","summary":"Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged ","content":"<p>Shares of&nbsp;<b>Aethlon Medical</b>(NASDAQ:<b><u>AEMD</u></b>) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.</p>\n<p>Aethlon Medical shared results last Thursday fortwo patients with Covid-19that were treated with the company’s Hemopurifier. According to the release, this is “a cartridge that is designed to filter viruses and exosomes from the blood.” In turn, the patients were treated over a total of nine sessions, and both showed improvements in their condition.</p>\n<p>Moreover, the Hemopurifier is designated as a“Breakthrough Device”by the U.S. Food and Drug Administration (FDA) for treating metastatic cancer. Now, the tool is now closely being looked at by the FDA through an early feasibility study.</p>\n<p>Charles J. Fisher, Jr., CEO of Aethlon Medical, said this about the AEMD stock news.</p>\n<blockquote>\n “The COVID-19 pandemic has affected the world over, prompting the need for innovative treatment approaches. We believe that the Hemopurifier® is such an innovation, as it is the only known device that can filter out exosomes, which are thought to play a role in the severity of infectious diseases like COVID-19. … These two case studies indicate that the Hemopurifier® was successfully able to clear SARS-CoV-2 virus and associated exosomes from the blood stream, resulting in a potential benefit for one of the critical COVID-19 patients that were treated.”\n</blockquote>\n<p>AEMD stock was up&nbsp;388% as of Wednesday afternoon.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-10 07:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.\nAethlon Medical shared...</p>\n\n<a href=\"https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AEMD":"Aethlon Medical Inc"},"source_url":"https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168166668","content_text":"Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.\nAethlon Medical shared results last Thursday fortwo patients with Covid-19that were treated with the company’s Hemopurifier. According to the release, this is “a cartridge that is designed to filter viruses and exosomes from the blood.” In turn, the patients were treated over a total of nine sessions, and both showed improvements in their condition.\nMoreover, the Hemopurifier is designated as a“Breakthrough Device”by the U.S. Food and Drug Administration (FDA) for treating metastatic cancer. Now, the tool is now closely being looked at by the FDA through an early feasibility study.\nCharles J. Fisher, Jr., CEO of Aethlon Medical, said this about the AEMD stock news.\n\n “The COVID-19 pandemic has affected the world over, prompting the need for innovative treatment approaches. We believe that the Hemopurifier® is such an innovation, as it is the only known device that can filter out exosomes, which are thought to play a role in the severity of infectious diseases like COVID-19. … These two case studies indicate that the Hemopurifier® was successfully able to clear SARS-CoV-2 virus and associated exosomes from the blood stream, resulting in a potential benefit for one of the critical COVID-19 patients that were treated.”\n\nAEMD stock was up 388% as of Wednesday afternoon.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4656977,"gmtCreate":1623282970008,"gmtModify":1663228318348,"authorId":3569554330947500,"author":{"id":3569554330947500,"idStr":"3569554330947500","authorId":3569554330947500,"name":"GraceChan","avatar":"https://static.tigerbbs.com/81c02019bb8fa5f8e43df505dfbe5c64","vip":1,"crmLevel":5,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":189552812,"type":1,"supId":0,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"}],"langContent":"EN"},{"id":189527109,"gmtCreate":1623282685401,"gmtModify":1704199894880,"author":{"id":"3585385605908328","authorId":"3585385605908328","name":"Thomas9413","avatar":"https://static.tigerbbs.com/effcfaa82ddb11a4fa57136b2a6f8351","vip":1,"hat":"https://static.tigerbbs.com/a3dee1aa3a3a3c1814833a4d3f8a5669","crmLevel":1,"crmLevelSwitch":0,"idStr":"3585385605908328","authorIdStr":"3585385605908328"},"htmlText":"Please comment .. thanks&nbsp;","listText":"Please comment .. thanks&nbsp;","text":"Please comment .. thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/189527109","repostId":1168166668,"repostType":4,"repost":{"id":"1168166668","kind":"news","pubTimestamp":1623281394,"share":"https://ttm.financial/m/news/1168166668?lang=&edition=fundamental","pubTime":"2021-06-10 07:29","market":"us","language":"en","title":"AEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%","url":"https://stock-news.laohu8.com/highlight/detail?id=1168166668","media":"investorplace","summary":"Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged ","content":"<p>Shares of&nbsp;<b>Aethlon Medical</b>(NASDAQ:<b><u>AEMD</u></b>) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.</p>\n<p>Aethlon Medical shared results last Thursday fortwo patients with Covid-19that were treated with the company’s Hemopurifier. According to the release, this is “a cartridge that is designed to filter viruses and exosomes from the blood.” In turn, the patients were treated over a total of nine sessions, and both showed improvements in their condition.</p>\n<p>Moreover, the Hemopurifier is designated as a“Breakthrough Device”by the U.S. Food and Drug Administration (FDA) for treating metastatic cancer. Now, the tool is now closely being looked at by the FDA through an early feasibility study.</p>\n<p>Charles J. Fisher, Jr., CEO of Aethlon Medical, said this about the AEMD stock news.</p>\n<blockquote>\n “The COVID-19 pandemic has affected the world over, prompting the need for innovative treatment approaches. We believe that the Hemopurifier® is such an innovation, as it is the only known device that can filter out exosomes, which are thought to play a role in the severity of infectious diseases like COVID-19. … These two case studies indicate that the Hemopurifier® was successfully able to clear SARS-CoV-2 virus and associated exosomes from the blood stream, resulting in a potential benefit for one of the critical COVID-19 patients that were treated.”\n</blockquote>\n<p>AEMD stock was up&nbsp;388% as of Wednesday afternoon.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-10 07:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.\nAethlon Medical shared...</p>\n\n<a href=\"https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AEMD":"Aethlon Medical Inc"},"source_url":"https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168166668","content_text":"Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.\nAethlon Medical shared results last Thursday fortwo patients with Covid-19that were treated with the company’s Hemopurifier. According to the release, this is “a cartridge that is designed to filter viruses and exosomes from the blood.” In turn, the patients were treated over a total of nine sessions, and both showed improvements in their condition.\nMoreover, the Hemopurifier is designated as a“Breakthrough Device”by the U.S. Food and Drug Administration (FDA) for treating metastatic cancer. Now, the tool is now closely being looked at by the FDA through an early feasibility study.\nCharles J. Fisher, Jr., CEO of Aethlon Medical, said this about the AEMD stock news.\n\n “The COVID-19 pandemic has affected the world over, prompting the need for innovative treatment approaches. We believe that the Hemopurifier® is such an innovation, as it is the only known device that can filter out exosomes, which are thought to play a role in the severity of infectious diseases like COVID-19. … These two case studies indicate that the Hemopurifier® was successfully able to clear SARS-CoV-2 virus and associated exosomes from the blood stream, resulting in a potential benefit for one of the critical COVID-19 patients that were treated.”\n\nAEMD stock was up 388% as of Wednesday afternoon.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4656920,"gmtCreate":1623282843926,"gmtModify":1663228318626,"authorId":3575256032463698,"author":{"id":3575256032463698,"idStr":"3575256032463698","authorId":3575256032463698,"name":"tearach","avatar":"https://static.tigerbbs.com/861adeae93387d8335f9550889bafb00","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":189527109,"type":1,"supId":0,"prevId":0,"content":"pls <u>like</u>","text":"pls <u>like</u>","html":"pls <u>like</u>"},{"id":4657362,"gmtCreate":1623283891532,"gmtModify":1635330142198,"authorId":3584000899703971,"author":{"id":3584000899703971,"idStr":"3584000899703971","authorId":3584000899703971,"name":"CGE","avatar":"https://static.tigerbbs.com/b8e167178f9d1ac99fa1763f8545f998","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":189527109,"type":1,"supId":4656920,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"}],"langContent":"EN"},{"id":189527080,"gmtCreate":1623282665340,"gmtModify":1704199894718,"author":{"id":"3575143606799200","authorId":"3575143606799200","name":"KK2021","avatar":"https://static.tigerbbs.com/e57decb2950e37ceb12176c97c9be2c4","vip":1,"hat":"https://static.tigerbbs.com/4c5ceab71416b120bab4604c0754b52a","crmLevel":9,"crmLevelSwitch":1,"idStr":"3575143606799200","authorIdStr":"3575143606799200"},"htmlText":"Pls like and comment","listText":"Pls like and comment","text":"Pls like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":4,"repostSize":0,"link":"https://ttm.financial/post/189527080","repostId":1168166668,"repostType":4,"repost":{"id":"1168166668","kind":"news","pubTimestamp":1623281394,"share":"https://ttm.financial/m/news/1168166668?lang=&edition=fundamental","pubTime":"2021-06-10 07:29","market":"us","language":"en","title":"AEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%","url":"https://stock-news.laohu8.com/highlight/detail?id=1168166668","media":"investorplace","summary":"Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged ","content":"<p>Shares of&nbsp;<b>Aethlon Medical</b>(NASDAQ:<b><u>AEMD</u></b>) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.</p>\n<p>Aethlon Medical shared results last Thursday fortwo patients with Covid-19that were treated with the company’s Hemopurifier. According to the release, this is “a cartridge that is designed to filter viruses and exosomes from the blood.” In turn, the patients were treated over a total of nine sessions, and both showed improvements in their condition.</p>\n<p>Moreover, the Hemopurifier is designated as a“Breakthrough Device”by the U.S. Food and Drug Administration (FDA) for treating metastatic cancer. Now, the tool is now closely being looked at by the FDA through an early feasibility study.</p>\n<p>Charles J. Fisher, Jr., CEO of Aethlon Medical, said this about the AEMD stock news.</p>\n<blockquote>\n “The COVID-19 pandemic has affected the world over, prompting the need for innovative treatment approaches. We believe that the Hemopurifier® is such an innovation, as it is the only known device that can filter out exosomes, which are thought to play a role in the severity of infectious diseases like COVID-19. … These two case studies indicate that the Hemopurifier® was successfully able to clear SARS-CoV-2 virus and associated exosomes from the blood stream, resulting in a potential benefit for one of the critical COVID-19 patients that were treated.”\n</blockquote>\n<p>AEMD stock was up&nbsp;388% as of Wednesday afternoon.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-10 07:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.\nAethlon Medical shared...</p>\n\n<a href=\"https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AEMD":"Aethlon Medical Inc"},"source_url":"https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168166668","content_text":"Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.\nAethlon Medical shared results last Thursday fortwo patients with Covid-19that were treated with the company’s Hemopurifier. According to the release, this is “a cartridge that is designed to filter viruses and exosomes from the blood.” In turn, the patients were treated over a total of nine sessions, and both showed improvements in their condition.\nMoreover, the Hemopurifier is designated as a“Breakthrough Device”by the U.S. Food and Drug Administration (FDA) for treating metastatic cancer. Now, the tool is now closely being looked at by the FDA through an early feasibility study.\nCharles J. Fisher, Jr., CEO of Aethlon Medical, said this about the AEMD stock news.\n\n “The COVID-19 pandemic has affected the world over, prompting the need for innovative treatment approaches. We believe that the Hemopurifier® is such an innovation, as it is the only known device that can filter out exosomes, which are thought to play a role in the severity of infectious diseases like COVID-19. … These two case studies indicate that the Hemopurifier® was successfully able to clear SARS-CoV-2 virus and associated exosomes from the blood stream, resulting in a potential benefit for one of the critical COVID-19 patients that were treated.”\n\nAEMD stock was up 388% as of Wednesday afternoon.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4674375,"gmtCreate":1623369589030,"gmtModify":1663228406334,"authorId":3575143606799200,"author":{"id":3575143606799200,"idStr":"3575143606799200","authorId":3575143606799200,"name":"KK2021","avatar":"https://static.tigerbbs.com/e57decb2950e37ceb12176c97c9be2c4","vip":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.29%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":9,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":189527080,"type":1,"supId":0,"prevId":0,"content":"<u>woww</u>","text":"<u>woww</u>","html":"<u>woww</u>"},{"id":4665755,"gmtCreate":1623321258691,"gmtModify":1663228363837,"authorId":3575143606799200,"author":{"id":3575143606799200,"idStr":"3575143606799200","authorId":3575143606799200,"name":"KK2021","avatar":"https://static.tigerbbs.com/e57decb2950e37ceb12176c97c9be2c4","vip":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.29%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":9,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":189527080,"type":1,"supId":0,"prevId":0,"content":"ok<br>","text":"ok<br>","html":"ok<br>"},{"id":4656852,"gmtCreate":1623282686683,"gmtModify":1663228317438,"authorId":3581334744371071,"author":{"id":3581334744371071,"idStr":"3581334744371071","authorId":3581334744371071,"name":"arachno73","avatar":"https://static.tigerbbs.com/863498a76b71cd34c7beeb14e7e8e66f","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":189527080,"type":1,"supId":0,"prevId":0,"content":"Like and comment back plew. Thanks.","text":"Like and comment back plew. Thanks.","html":"Like and comment back plew. Thanks."},{"id":4656859,"gmtCreate":1623282707771,"gmtModify":1663228317329,"authorId":3575143606799200,"author":{"id":3575143606799200,"idStr":"3575143606799200","authorId":3575143606799200,"name":"KK2021","avatar":"https://static.tigerbbs.com/e57decb2950e37ceb12176c97c9be2c4","vip":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.29%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":9,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":189527080,"type":1,"supId":4656852,"prevId":0,"content":"pls commmet and like","text":"pls commmet and like","html":"pls commmet and like"}],"langContent":"EN"},{"id":189529153,"gmtCreate":1623282394472,"gmtModify":1704199884404,"author":{"id":"3565819252889467","authorId":"3565819252889467","name":"e13v3n","avatar":"https://static.tigerbbs.com/387ab24895655e32d7ddaf87ded7da37","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3565819252889467","authorIdStr":"3565819252889467"},"htmlText":"pls like n comment","listText":"pls like n comment","text":"pls like n comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/189529153","repostId":1168166668,"repostType":4,"repost":{"id":"1168166668","kind":"news","pubTimestamp":1623281394,"share":"https://ttm.financial/m/news/1168166668?lang=&edition=fundamental","pubTime":"2021-06-10 07:29","market":"us","language":"en","title":"AEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%","url":"https://stock-news.laohu8.com/highlight/detail?id=1168166668","media":"investorplace","summary":"Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged ","content":"<p>Shares of&nbsp;<b>Aethlon Medical</b>(NASDAQ:<b><u>AEMD</u></b>) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.</p>\n<p>Aethlon Medical shared results last Thursday fortwo patients with Covid-19that were treated with the company’s Hemopurifier. According to the release, this is “a cartridge that is designed to filter viruses and exosomes from the blood.” In turn, the patients were treated over a total of nine sessions, and both showed improvements in their condition.</p>\n<p>Moreover, the Hemopurifier is designated as a“Breakthrough Device”by the U.S. Food and Drug Administration (FDA) for treating metastatic cancer. Now, the tool is now closely being looked at by the FDA through an early feasibility study.</p>\n<p>Charles J. Fisher, Jr., CEO of Aethlon Medical, said this about the AEMD stock news.</p>\n<blockquote>\n “The COVID-19 pandemic has affected the world over, prompting the need for innovative treatment approaches. We believe that the Hemopurifier® is such an innovation, as it is the only known device that can filter out exosomes, which are thought to play a role in the severity of infectious diseases like COVID-19. … These two case studies indicate that the Hemopurifier® was successfully able to clear SARS-CoV-2 virus and associated exosomes from the blood stream, resulting in a potential benefit for one of the critical COVID-19 patients that were treated.”\n</blockquote>\n<p>AEMD stock was up&nbsp;388% as of Wednesday afternoon.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-10 07:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.\nAethlon Medical shared...</p>\n\n<a href=\"https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AEMD":"Aethlon Medical Inc"},"source_url":"https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168166668","content_text":"Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.\nAethlon Medical shared results last Thursday fortwo patients with Covid-19that were treated with the company’s Hemopurifier. According to the release, this is “a cartridge that is designed to filter viruses and exosomes from the blood.” In turn, the patients were treated over a total of nine sessions, and both showed improvements in their condition.\nMoreover, the Hemopurifier is designated as a“Breakthrough Device”by the U.S. Food and Drug Administration (FDA) for treating metastatic cancer. Now, the tool is now closely being looked at by the FDA through an early feasibility study.\nCharles J. Fisher, Jr., CEO of Aethlon Medical, said this about the AEMD stock news.\n\n “The COVID-19 pandemic has affected the world over, prompting the need for innovative treatment approaches. We believe that the Hemopurifier® is such an innovation, as it is the only known device that can filter out exosomes, which are thought to play a role in the severity of infectious diseases like COVID-19. … These two case studies indicate that the Hemopurifier® was successfully able to clear SARS-CoV-2 virus and associated exosomes from the blood stream, resulting in a potential benefit for one of the critical COVID-19 patients that were treated.”\n\nAEMD stock was up 388% as of Wednesday afternoon.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4656932,"gmtCreate":1623282870088,"gmtModify":1663228319231,"authorId":3575256032463698,"author":{"id":3575256032463698,"idStr":"3575256032463698","authorId":3575256032463698,"name":"tearach","avatar":"https://static.tigerbbs.com/861adeae93387d8335f9550889bafb00","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":189529153,"type":1,"supId":0,"prevId":0,"content":"pls <u>comment</u>","text":"pls <u>comment</u>","html":"pls <u>comment</u>"}],"langContent":"EN"},{"id":189564191,"gmtCreate":1623282275913,"gmtModify":1704199881317,"author":{"id":"3570069153864313","authorId":"3570069153864313","name":"Racheltestin","avatar":"https://static.tigerbbs.com/83746feea9af3c17ae42ff00d7ca9254","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3570069153864313","authorIdStr":"3570069153864313"},"htmlText":"Like and comment pls!&nbsp;","listText":"Like and comment pls!&nbsp;","text":"Like and comment pls!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/189564191","repostId":1168166668,"repostType":4,"repost":{"id":"1168166668","kind":"news","pubTimestamp":1623281394,"share":"https://ttm.financial/m/news/1168166668?lang=&edition=fundamental","pubTime":"2021-06-10 07:29","market":"us","language":"en","title":"AEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%","url":"https://stock-news.laohu8.com/highlight/detail?id=1168166668","media":"investorplace","summary":"Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged ","content":"<p>Shares of&nbsp;<b>Aethlon Medical</b>(NASDAQ:<b><u>AEMD</u></b>) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.</p>\n<p>Aethlon Medical shared results last Thursday fortwo patients with Covid-19that were treated with the company’s Hemopurifier. According to the release, this is “a cartridge that is designed to filter viruses and exosomes from the blood.” In turn, the patients were treated over a total of nine sessions, and both showed improvements in their condition.</p>\n<p>Moreover, the Hemopurifier is designated as a“Breakthrough Device”by the U.S. Food and Drug Administration (FDA) for treating metastatic cancer. Now, the tool is now closely being looked at by the FDA through an early feasibility study.</p>\n<p>Charles J. Fisher, Jr., CEO of Aethlon Medical, said this about the AEMD stock news.</p>\n<blockquote>\n “The COVID-19 pandemic has affected the world over, prompting the need for innovative treatment approaches. We believe that the Hemopurifier® is such an innovation, as it is the only known device that can filter out exosomes, which are thought to play a role in the severity of infectious diseases like COVID-19. … These two case studies indicate that the Hemopurifier® was successfully able to clear SARS-CoV-2 virus and associated exosomes from the blood stream, resulting in a potential benefit for one of the critical COVID-19 patients that were treated.”\n</blockquote>\n<p>AEMD stock was up&nbsp;388% as of Wednesday afternoon.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-10 07:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.\nAethlon Medical shared...</p>\n\n<a href=\"https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AEMD":"Aethlon Medical Inc"},"source_url":"https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168166668","content_text":"Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.\nAethlon Medical shared results last Thursday fortwo patients with Covid-19that were treated with the company’s Hemopurifier. According to the release, this is “a cartridge that is designed to filter viruses and exosomes from the blood.” In turn, the patients were treated over a total of nine sessions, and both showed improvements in their condition.\nMoreover, the Hemopurifier is designated as a“Breakthrough Device”by the U.S. Food and Drug Administration (FDA) for treating metastatic cancer. Now, the tool is now closely being looked at by the FDA through an early feasibility study.\nCharles J. Fisher, Jr., CEO of Aethlon Medical, said this about the AEMD stock news.\n\n “The COVID-19 pandemic has affected the world over, prompting the need for innovative treatment approaches. We believe that the Hemopurifier® is such an innovation, as it is the only known device that can filter out exosomes, which are thought to play a role in the severity of infectious diseases like COVID-19. … These two case studies indicate that the Hemopurifier® was successfully able to clear SARS-CoV-2 virus and associated exosomes from the blood stream, resulting in a potential benefit for one of the critical COVID-19 patients that were treated.”\n\nAEMD stock was up 388% as of Wednesday afternoon.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4656924,"gmtCreate":1623282854680,"gmtModify":1663228319049,"authorId":3575256032463698,"author":{"id":3575256032463698,"idStr":"3575256032463698","authorId":3575256032463698,"name":"tearach","avatar":"https://static.tigerbbs.com/861adeae93387d8335f9550889bafb00","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":189564191,"type":1,"supId":0,"prevId":0,"content":"pls like","text":"pls like","html":"pls like"}],"langContent":"EN"},{"id":189565932,"gmtCreate":1623282240026,"gmtModify":1704199878366,"author":{"id":"3568795661912400","authorId":"3568795661912400","name":"Ash1285","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3568795661912400","authorIdStr":"3568795661912400"},"htmlText":"Wow..pls like and comment thanks","listText":"Wow..pls like and comment thanks","text":"Wow..pls like and comment thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/189565932","repostId":1168166668,"repostType":4,"repost":{"id":"1168166668","kind":"news","pubTimestamp":1623281394,"share":"https://ttm.financial/m/news/1168166668?lang=&edition=fundamental","pubTime":"2021-06-10 07:29","market":"us","language":"en","title":"AEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%","url":"https://stock-news.laohu8.com/highlight/detail?id=1168166668","media":"investorplace","summary":"Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged ","content":"<p>Shares of&nbsp;<b>Aethlon Medical</b>(NASDAQ:<b><u>AEMD</u></b>) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.</p>\n<p>Aethlon Medical shared results last Thursday fortwo patients with Covid-19that were treated with the company’s Hemopurifier. According to the release, this is “a cartridge that is designed to filter viruses and exosomes from the blood.” In turn, the patients were treated over a total of nine sessions, and both showed improvements in their condition.</p>\n<p>Moreover, the Hemopurifier is designated as a“Breakthrough Device”by the U.S. Food and Drug Administration (FDA) for treating metastatic cancer. Now, the tool is now closely being looked at by the FDA through an early feasibility study.</p>\n<p>Charles J. Fisher, Jr., CEO of Aethlon Medical, said this about the AEMD stock news.</p>\n<blockquote>\n “The COVID-19 pandemic has affected the world over, prompting the need for innovative treatment approaches. We believe that the Hemopurifier® is such an innovation, as it is the only known device that can filter out exosomes, which are thought to play a role in the severity of infectious diseases like COVID-19. … These two case studies indicate that the Hemopurifier® was successfully able to clear SARS-CoV-2 virus and associated exosomes from the blood stream, resulting in a potential benefit for one of the critical COVID-19 patients that were treated.”\n</blockquote>\n<p>AEMD stock was up&nbsp;388% as of Wednesday afternoon.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-10 07:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.\nAethlon Medical shared...</p>\n\n<a href=\"https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AEMD":"Aethlon Medical Inc"},"source_url":"https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168166668","content_text":"Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.\nAethlon Medical shared results last Thursday fortwo patients with Covid-19that were treated with the company’s Hemopurifier. According to the release, this is “a cartridge that is designed to filter viruses and exosomes from the blood.” In turn, the patients were treated over a total of nine sessions, and both showed improvements in their condition.\nMoreover, the Hemopurifier is designated as a“Breakthrough Device”by the U.S. Food and Drug Administration (FDA) for treating metastatic cancer. Now, the tool is now closely being looked at by the FDA through an early feasibility study.\nCharles J. Fisher, Jr., CEO of Aethlon Medical, said this about the AEMD stock news.\n\n “The COVID-19 pandemic has affected the world over, prompting the need for innovative treatment approaches. We believe that the Hemopurifier® is such an innovation, as it is the only known device that can filter out exosomes, which are thought to play a role in the severity of infectious diseases like COVID-19. … These two case studies indicate that the Hemopurifier® was successfully able to clear SARS-CoV-2 virus and associated exosomes from the blood stream, resulting in a potential benefit for one of the critical COVID-19 patients that were treated.”\n\nAEMD stock was up 388% as of Wednesday afternoon.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4656936,"gmtCreate":1623282876034,"gmtModify":1663228319046,"authorId":3575256032463698,"author":{"id":3575256032463698,"idStr":"3575256032463698","authorId":3575256032463698,"name":"tearach","avatar":"https://static.tigerbbs.com/861adeae93387d8335f9550889bafb00","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":189565932,"type":1,"supId":4656729,"prevId":0,"content":"pls <u>comment</u>","text":"pls <u>comment</u>","html":"pls <u>comment</u>"},{"id":4656729,"gmtCreate":1623282407248,"gmtModify":1663228314246,"authorId":3565819252889467,"author":{"id":3565819252889467,"idStr":"3565819252889467","authorId":3565819252889467,"name":"e13v3n","avatar":"https://static.tigerbbs.com/387ab24895655e32d7ddaf87ded7da37","vip":1,"currentWearingBadge":{"badgeId":"29815c1501c442c58b708482689df577-1","templateUuid":"29815c1501c442c58b708482689df577","name":"Emerging Contributor","description":"Contributors who received Editor's Pick for the 1st time","bigImgUrl":"https://static.tigerbbs.com/4ce9180a952c61a51c39f70d533b81a7","smallImgUrl":"https://static.tigerbbs.com/f98cf16cf4b858114f7ab9a779f9e6f1","redirectLinkEnabled":1,"redirectLink":"https://ttm.financial/TW/9000980585","hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.06.12","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":2005},"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":189565932,"type":1,"supId":0,"prevId":0,"content":"pl reply","text":"pl reply","html":"pl reply"},{"id":4660519,"gmtCreate":1623293105137,"gmtModify":1635329821464,"authorId":3568795661912400,"author":{"id":3568795661912400,"idStr":"3568795661912400","authorId":3568795661912400,"name":"Ash1285","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":189565932,"type":1,"supId":4656729,"prevId":0,"content":"thanks","text":"thanks","html":"thanks"}],"langContent":"EN"},{"id":189569393,"gmtCreate":1623282081712,"gmtModify":1704199869718,"author":{"id":"3572398673005116","authorId":"3572398673005116","name":"TraderGw","avatar":"https://static.tigerbbs.com/aca8db80dc59388010d0fbbafecdeb6e","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3572398673005116","authorIdStr":"3572398673005116"},"htmlText":"Like and comment&nbsp;","listText":"Like and comment&nbsp;","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/189569393","repostId":1168166668,"repostType":4,"repost":{"id":"1168166668","kind":"news","pubTimestamp":1623281394,"share":"https://ttm.financial/m/news/1168166668?lang=&edition=fundamental","pubTime":"2021-06-10 07:29","market":"us","language":"en","title":"AEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%","url":"https://stock-news.laohu8.com/highlight/detail?id=1168166668","media":"investorplace","summary":"Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged ","content":"<p>Shares of&nbsp;<b>Aethlon Medical</b>(NASDAQ:<b><u>AEMD</u></b>) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.</p>\n<p>Aethlon Medical shared results last Thursday fortwo patients with Covid-19that were treated with the company’s Hemopurifier. According to the release, this is “a cartridge that is designed to filter viruses and exosomes from the blood.” In turn, the patients were treated over a total of nine sessions, and both showed improvements in their condition.</p>\n<p>Moreover, the Hemopurifier is designated as a“Breakthrough Device”by the U.S. Food and Drug Administration (FDA) for treating metastatic cancer. Now, the tool is now closely being looked at by the FDA through an early feasibility study.</p>\n<p>Charles J. Fisher, Jr., CEO of Aethlon Medical, said this about the AEMD stock news.</p>\n<blockquote>\n “The COVID-19 pandemic has affected the world over, prompting the need for innovative treatment approaches. We believe that the Hemopurifier® is such an innovation, as it is the only known device that can filter out exosomes, which are thought to play a role in the severity of infectious diseases like COVID-19. … These two case studies indicate that the Hemopurifier® was successfully able to clear SARS-CoV-2 virus and associated exosomes from the blood stream, resulting in a potential benefit for one of the critical COVID-19 patients that were treated.”\n</blockquote>\n<p>AEMD stock was up&nbsp;388% as of Wednesday afternoon.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-10 07:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.\nAethlon Medical shared...</p>\n\n<a href=\"https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AEMD":"Aethlon Medical Inc"},"source_url":"https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168166668","content_text":"Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.\nAethlon Medical shared results last Thursday fortwo patients with Covid-19that were treated with the company’s Hemopurifier. According to the release, this is “a cartridge that is designed to filter viruses and exosomes from the blood.” In turn, the patients were treated over a total of nine sessions, and both showed improvements in their condition.\nMoreover, the Hemopurifier is designated as a“Breakthrough Device”by the U.S. Food and Drug Administration (FDA) for treating metastatic cancer. Now, the tool is now closely being looked at by the FDA through an early feasibility study.\nCharles J. Fisher, Jr., CEO of Aethlon Medical, said this about the AEMD stock news.\n\n “The COVID-19 pandemic has affected the world over, prompting the need for innovative treatment approaches. We believe that the Hemopurifier® is such an innovation, as it is the only known device that can filter out exosomes, which are thought to play a role in the severity of infectious diseases like COVID-19. … These two case studies indicate that the Hemopurifier® was successfully able to clear SARS-CoV-2 virus and associated exosomes from the blood stream, resulting in a potential benefit for one of the critical COVID-19 patients that were treated.”\n\nAEMD stock was up 388% as of Wednesday afternoon.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4656641,"gmtCreate":1623282203372,"gmtModify":1663228315951,"authorId":3568795661912400,"author":{"id":3568795661912400,"idStr":"3568795661912400","authorId":3568795661912400,"name":"Ash1285","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":189569393,"type":1,"supId":0,"prevId":0,"content":"Yes","text":"Yes","html":"Yes"}],"langContent":"EN"},{"id":189587184,"gmtCreate":1623282031548,"gmtModify":1704199866278,"author":{"id":"3555237785078725","authorId":"3555237785078725","name":"许哲东","avatar":"https://static.tigerbbs.com/9061503cb3d4f9ac3d7d9de3f72b29ab","vip":1,"hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":6,"crmLevelSwitch":1,"idStr":"3555237785078725","authorIdStr":"3555237785078725"},"htmlText":"Another AMC stock with no limit rising..like and comment please","listText":"Another AMC stock with no limit rising..like and comment please","text":"Another AMC stock with no limit rising..like and comment please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/189587184","repostId":1168166668,"repostType":4,"repost":{"id":"1168166668","kind":"news","pubTimestamp":1623281394,"share":"https://ttm.financial/m/news/1168166668?lang=&edition=fundamental","pubTime":"2021-06-10 07:29","market":"us","language":"en","title":"AEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%","url":"https://stock-news.laohu8.com/highlight/detail?id=1168166668","media":"investorplace","summary":"Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged ","content":"<p>Shares of&nbsp;<b>Aethlon Medical</b>(NASDAQ:<b><u>AEMD</u></b>) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.</p>\n<p>Aethlon Medical shared results last Thursday fortwo patients with Covid-19that were treated with the company’s Hemopurifier. According to the release, this is “a cartridge that is designed to filter viruses and exosomes from the blood.” In turn, the patients were treated over a total of nine sessions, and both showed improvements in their condition.</p>\n<p>Moreover, the Hemopurifier is designated as a“Breakthrough Device”by the U.S. Food and Drug Administration (FDA) for treating metastatic cancer. Now, the tool is now closely being looked at by the FDA through an early feasibility study.</p>\n<p>Charles J. Fisher, Jr., CEO of Aethlon Medical, said this about the AEMD stock news.</p>\n<blockquote>\n “The COVID-19 pandemic has affected the world over, prompting the need for innovative treatment approaches. We believe that the Hemopurifier® is such an innovation, as it is the only known device that can filter out exosomes, which are thought to play a role in the severity of infectious diseases like COVID-19. … These two case studies indicate that the Hemopurifier® was successfully able to clear SARS-CoV-2 virus and associated exosomes from the blood stream, resulting in a potential benefit for one of the critical COVID-19 patients that were treated.”\n</blockquote>\n<p>AEMD stock was up&nbsp;388% as of Wednesday afternoon.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-10 07:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.\nAethlon Medical shared...</p>\n\n<a href=\"https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AEMD":"Aethlon Medical Inc"},"source_url":"https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168166668","content_text":"Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.\nAethlon Medical shared results last Thursday fortwo patients with Covid-19that were treated with the company’s Hemopurifier. According to the release, this is “a cartridge that is designed to filter viruses and exosomes from the blood.” In turn, the patients were treated over a total of nine sessions, and both showed improvements in their condition.\nMoreover, the Hemopurifier is designated as a“Breakthrough Device”by the U.S. Food and Drug Administration (FDA) for treating metastatic cancer. Now, the tool is now closely being looked at by the FDA through an early feasibility study.\nCharles J. Fisher, Jr., CEO of Aethlon Medical, said this about the AEMD stock news.\n\n “The COVID-19 pandemic has affected the world over, prompting the need for innovative treatment approaches. We believe that the Hemopurifier® is such an innovation, as it is the only known device that can filter out exosomes, which are thought to play a role in the severity of infectious diseases like COVID-19. … These two case studies indicate that the Hemopurifier® was successfully able to clear SARS-CoV-2 virus and associated exosomes from the blood stream, resulting in a potential benefit for one of the critical COVID-19 patients that were treated.”\n\nAEMD stock was up 388% as of Wednesday afternoon.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4656739,"gmtCreate":1623282417839,"gmtModify":1663228318230,"authorId":3565819252889467,"author":{"id":3565819252889467,"idStr":"3565819252889467","authorId":3565819252889467,"name":"e13v3n","avatar":"https://static.tigerbbs.com/387ab24895655e32d7ddaf87ded7da37","vip":1,"currentWearingBadge":{"badgeId":"29815c1501c442c58b708482689df577-1","templateUuid":"29815c1501c442c58b708482689df577","name":"Emerging Contributor","description":"Contributors who received Editor's Pick for the 1st time","bigImgUrl":"https://static.tigerbbs.com/4ce9180a952c61a51c39f70d533b81a7","smallImgUrl":"https://static.tigerbbs.com/f98cf16cf4b858114f7ab9a779f9e6f1","redirectLinkEnabled":1,"redirectLink":"https://ttm.financial/TW/9000980585","hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.06.12","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":2005},"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":189587184,"type":1,"supId":0,"prevId":0,"content":"pl reply","text":"pl reply","html":"pl reply"}],"langContent":"EN"},{"id":189584210,"gmtCreate":1623282015030,"gmtModify":1704199865299,"author":{"id":"3576274545052910","authorId":"3576274545052910","name":"Kevin92","avatar":"https://static.tigerbbs.com/c5ff4addbbdb8d9d15fec29f9709b0c3","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3576274545052910","authorIdStr":"3576274545052910"},"htmlText":"Like and commnet","listText":"Like and commnet","text":"Like and commnet","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/189584210","repostId":1168166668,"repostType":4,"repost":{"id":"1168166668","kind":"news","pubTimestamp":1623281394,"share":"https://ttm.financial/m/news/1168166668?lang=&edition=fundamental","pubTime":"2021-06-10 07:29","market":"us","language":"en","title":"AEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%","url":"https://stock-news.laohu8.com/highlight/detail?id=1168166668","media":"investorplace","summary":"Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged ","content":"<p>Shares of&nbsp;<b>Aethlon Medical</b>(NASDAQ:<b><u>AEMD</u></b>) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.</p>\n<p>Aethlon Medical shared results last Thursday fortwo patients with Covid-19that were treated with the company’s Hemopurifier. According to the release, this is “a cartridge that is designed to filter viruses and exosomes from the blood.” In turn, the patients were treated over a total of nine sessions, and both showed improvements in their condition.</p>\n<p>Moreover, the Hemopurifier is designated as a“Breakthrough Device”by the U.S. Food and Drug Administration (FDA) for treating metastatic cancer. Now, the tool is now closely being looked at by the FDA through an early feasibility study.</p>\n<p>Charles J. Fisher, Jr., CEO of Aethlon Medical, said this about the AEMD stock news.</p>\n<blockquote>\n “The COVID-19 pandemic has affected the world over, prompting the need for innovative treatment approaches. We believe that the Hemopurifier® is such an innovation, as it is the only known device that can filter out exosomes, which are thought to play a role in the severity of infectious diseases like COVID-19. … These two case studies indicate that the Hemopurifier® was successfully able to clear SARS-CoV-2 virus and associated exosomes from the blood stream, resulting in a potential benefit for one of the critical COVID-19 patients that were treated.”\n</blockquote>\n<p>AEMD stock was up&nbsp;388% as of Wednesday afternoon.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-10 07:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.\nAethlon Medical shared...</p>\n\n<a href=\"https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AEMD":"Aethlon Medical Inc"},"source_url":"https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168166668","content_text":"Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.\nAethlon Medical shared results last Thursday fortwo patients with Covid-19that were treated with the company’s Hemopurifier. According to the release, this is “a cartridge that is designed to filter viruses and exosomes from the blood.” In turn, the patients were treated over a total of nine sessions, and both showed improvements in their condition.\nMoreover, the Hemopurifier is designated as a“Breakthrough Device”by the U.S. Food and Drug Administration (FDA) for treating metastatic cancer. Now, the tool is now closely being looked at by the FDA through an early feasibility study.\nCharles J. Fisher, Jr., CEO of Aethlon Medical, said this about the AEMD stock news.\n\n “The COVID-19 pandemic has affected the world over, prompting the need for innovative treatment approaches. We believe that the Hemopurifier® is such an innovation, as it is the only known device that can filter out exosomes, which are thought to play a role in the severity of infectious diseases like COVID-19. … These two case studies indicate that the Hemopurifier® was successfully able to clear SARS-CoV-2 virus and associated exosomes from the blood stream, resulting in a potential benefit for one of the critical COVID-19 patients that were treated.”\n\nAEMD stock was up 388% as of Wednesday afternoon.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4656646,"gmtCreate":1623282215616,"gmtModify":1663228314138,"authorId":3568795661912400,"author":{"id":3568795661912400,"idStr":"3568795661912400","authorId":3568795661912400,"name":"Ash1285","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":189584210,"type":1,"supId":0,"prevId":0,"content":"Yes","text":"Yes","html":"Yes"}],"langContent":"EN"},{"id":189588203,"gmtCreate":1623281918702,"gmtModify":1704199859744,"author":{"id":"3581823222182692","authorId":"3581823222182692","name":"AJAJ","avatar":"https://static.tigerbbs.com/d39956ed0487a0f393611b7d94da0db0","vip":1,"hat":"https://static.tigerbbs.com/a3dee1aa3a3a3c1814833a4d3f8a5669","crmLevel":2,"crmLevelSwitch":0,"idStr":"3581823222182692","authorIdStr":"3581823222182692"},"htmlText":"Pls like and comment&nbsp;","listText":"Pls like and comment&nbsp;","text":"Pls like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/189588203","repostId":1168166668,"repostType":4,"repost":{"id":"1168166668","kind":"news","pubTimestamp":1623281394,"share":"https://ttm.financial/m/news/1168166668?lang=&edition=fundamental","pubTime":"2021-06-10 07:29","market":"us","language":"en","title":"AEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%","url":"https://stock-news.laohu8.com/highlight/detail?id=1168166668","media":"investorplace","summary":"Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged ","content":"<p>Shares of&nbsp;<b>Aethlon Medical</b>(NASDAQ:<b><u>AEMD</u></b>) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.</p>\n<p>Aethlon Medical shared results last Thursday fortwo patients with Covid-19that were treated with the company’s Hemopurifier. According to the release, this is “a cartridge that is designed to filter viruses and exosomes from the blood.” In turn, the patients were treated over a total of nine sessions, and both showed improvements in their condition.</p>\n<p>Moreover, the Hemopurifier is designated as a“Breakthrough Device”by the U.S. Food and Drug Administration (FDA) for treating metastatic cancer. Now, the tool is now closely being looked at by the FDA through an early feasibility study.</p>\n<p>Charles J. Fisher, Jr., CEO of Aethlon Medical, said this about the AEMD stock news.</p>\n<blockquote>\n “The COVID-19 pandemic has affected the world over, prompting the need for innovative treatment approaches. We believe that the Hemopurifier® is such an innovation, as it is the only known device that can filter out exosomes, which are thought to play a role in the severity of infectious diseases like COVID-19. … These two case studies indicate that the Hemopurifier® was successfully able to clear SARS-CoV-2 virus and associated exosomes from the blood stream, resulting in a potential benefit for one of the critical COVID-19 patients that were treated.”\n</blockquote>\n<p>AEMD stock was up&nbsp;388% as of Wednesday afternoon.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-10 07:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.\nAethlon Medical shared...</p>\n\n<a href=\"https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AEMD":"Aethlon Medical Inc"},"source_url":"https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168166668","content_text":"Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.\nAethlon Medical shared results last Thursday fortwo patients with Covid-19that were treated with the company’s Hemopurifier. According to the release, this is “a cartridge that is designed to filter viruses and exosomes from the blood.” In turn, the patients were treated over a total of nine sessions, and both showed improvements in their condition.\nMoreover, the Hemopurifier is designated as a“Breakthrough Device”by the U.S. Food and Drug Administration (FDA) for treating metastatic cancer. Now, the tool is now closely being looked at by the FDA through an early feasibility study.\nCharles J. Fisher, Jr., CEO of Aethlon Medical, said this about the AEMD stock news.\n\n “The COVID-19 pandemic has affected the world over, prompting the need for innovative treatment approaches. We believe that the Hemopurifier® is such an innovation, as it is the only known device that can filter out exosomes, which are thought to play a role in the severity of infectious diseases like COVID-19. … These two case studies indicate that the Hemopurifier® was successfully able to clear SARS-CoV-2 virus and associated exosomes from the blood stream, resulting in a potential benefit for one of the critical COVID-19 patients that were treated.”\n\nAEMD stock was up 388% as of Wednesday afternoon.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4656562,"gmtCreate":1623282008677,"gmtModify":1635330224888,"authorId":3576274545052910,"author":{"id":3576274545052910,"idStr":"3576274545052910","authorId":3576274545052910,"name":"Kevin92","avatar":"https://static.tigerbbs.com/c5ff4addbbdb8d9d15fec29f9709b0c3","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":189588203,"type":1,"supId":0,"prevId":0,"content":"Like and commnet","text":"Like and commnet","html":"Like and commnet"}],"langContent":"EN"},{"id":189581745,"gmtCreate":1623281900687,"gmtModify":1704199858773,"author":{"id":"3557629001242050","authorId":"3557629001242050","name":"kksuen","avatar":"https://static.tigerbbs.com/e1eb0ceb998a78cefb82c2f66d2addb1","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3557629001242050","authorIdStr":"3557629001242050"},"htmlText":"Comment and like pls","listText":"Comment and like pls","text":"Comment and like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":4,"repostSize":0,"link":"https://ttm.financial/post/189581745","repostId":1168166668,"repostType":4,"repost":{"id":"1168166668","kind":"news","pubTimestamp":1623281394,"share":"https://ttm.financial/m/news/1168166668?lang=&edition=fundamental","pubTime":"2021-06-10 07:29","market":"us","language":"en","title":"AEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%","url":"https://stock-news.laohu8.com/highlight/detail?id=1168166668","media":"investorplace","summary":"Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged ","content":"<p>Shares of&nbsp;<b>Aethlon Medical</b>(NASDAQ:<b><u>AEMD</u></b>) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.</p>\n<p>Aethlon Medical shared results last Thursday fortwo patients with Covid-19that were treated with the company’s Hemopurifier. According to the release, this is “a cartridge that is designed to filter viruses and exosomes from the blood.” In turn, the patients were treated over a total of nine sessions, and both showed improvements in their condition.</p>\n<p>Moreover, the Hemopurifier is designated as a“Breakthrough Device”by the U.S. Food and Drug Administration (FDA) for treating metastatic cancer. Now, the tool is now closely being looked at by the FDA through an early feasibility study.</p>\n<p>Charles J. Fisher, Jr., CEO of Aethlon Medical, said this about the AEMD stock news.</p>\n<blockquote>\n “The COVID-19 pandemic has affected the world over, prompting the need for innovative treatment approaches. We believe that the Hemopurifier® is such an innovation, as it is the only known device that can filter out exosomes, which are thought to play a role in the severity of infectious diseases like COVID-19. … These two case studies indicate that the Hemopurifier® was successfully able to clear SARS-CoV-2 virus and associated exosomes from the blood stream, resulting in a potential benefit for one of the critical COVID-19 patients that were treated.”\n</blockquote>\n<p>AEMD stock was up&nbsp;388% as of Wednesday afternoon.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-10 07:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.\nAethlon Medical shared...</p>\n\n<a href=\"https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AEMD":"Aethlon Medical Inc"},"source_url":"https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168166668","content_text":"Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.\nAethlon Medical shared results last Thursday fortwo patients with Covid-19that were treated with the company’s Hemopurifier. According to the release, this is “a cartridge that is designed to filter viruses and exosomes from the blood.” In turn, the patients were treated over a total of nine sessions, and both showed improvements in their condition.\nMoreover, the Hemopurifier is designated as a“Breakthrough Device”by the U.S. Food and Drug Administration (FDA) for treating metastatic cancer. Now, the tool is now closely being looked at by the FDA through an early feasibility study.\nCharles J. Fisher, Jr., CEO of Aethlon Medical, said this about the AEMD stock news.\n\n “The COVID-19 pandemic has affected the world over, prompting the need for innovative treatment approaches. We believe that the Hemopurifier® is such an innovation, as it is the only known device that can filter out exosomes, which are thought to play a role in the severity of infectious diseases like COVID-19. … These two case studies indicate that the Hemopurifier® was successfully able to clear SARS-CoV-2 virus and associated exosomes from the blood stream, resulting in a potential benefit for one of the critical COVID-19 patients that were treated.”\n\nAEMD stock was up 388% as of Wednesday afternoon.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4658582,"gmtCreate":1623286778832,"gmtModify":1663228326033,"authorId":3581823222182692,"author":{"id":3581823222182692,"idStr":"3581823222182692","authorId":3581823222182692,"name":"AJAJ","avatar":"https://static.tigerbbs.com/d39956ed0487a0f393611b7d94da0db0","vip":1,"currentWearingBadge":{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.01.14","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1001},"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":189581745,"type":1,"supId":4656518,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"},{"id":4656516,"gmtCreate":1623281930633,"gmtModify":1663228317434,"authorId":3567414666000785,"author":{"id":3567414666000785,"idStr":"3567414666000785","authorId":3567414666000785,"name":"milliongal","avatar":"https://static.tigerbbs.com/6f6257a8cb1bd34fdce9908d40caf540","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":189581745,"type":1,"supId":0,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"},{"id":4656518,"gmtCreate":1623281933254,"gmtModify":1663228315948,"authorId":3581823222182692,"author":{"id":3581823222182692,"idStr":"3581823222182692","authorId":3581823222182692,"name":"AJAJ","avatar":"https://static.tigerbbs.com/d39956ed0487a0f393611b7d94da0db0","vip":1,"currentWearingBadge":{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.01.14","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1001},"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":189581745,"type":1,"supId":0,"prevId":0,"content":"Ok pls reply","text":"Ok pls reply","html":"Ok pls reply"},{"id":4656746,"gmtCreate":1623282440716,"gmtModify":1663228315230,"authorId":3557629001242050,"author":{"id":3557629001242050,"idStr":"3557629001242050","authorId":3557629001242050,"name":"kksuen","avatar":"https://static.tigerbbs.com/e1eb0ceb998a78cefb82c2f66d2addb1","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":189581745,"type":1,"supId":4656518,"prevId":0,"content":"ok like this comment back too","text":"ok like this comment back too","html":"ok like this comment back too"}],"langContent":"EN"},{"id":189581636,"gmtCreate":1623281891725,"gmtModify":1704199857959,"author":{"id":"3567414666000785","authorId":"3567414666000785","name":"milliongal","avatar":"https://static.tigerbbs.com/6f6257a8cb1bd34fdce9908d40caf540","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3567414666000785","authorIdStr":"3567414666000785"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/189581636","repostId":1168166668,"repostType":4,"repost":{"id":"1168166668","kind":"news","pubTimestamp":1623281394,"share":"https://ttm.financial/m/news/1168166668?lang=&edition=fundamental","pubTime":"2021-06-10 07:29","market":"us","language":"en","title":"AEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%","url":"https://stock-news.laohu8.com/highlight/detail?id=1168166668","media":"investorplace","summary":"Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged ","content":"<p>Shares of&nbsp;<b>Aethlon Medical</b>(NASDAQ:<b><u>AEMD</u></b>) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.</p>\n<p>Aethlon Medical shared results last Thursday fortwo patients with Covid-19that were treated with the company’s Hemopurifier. According to the release, this is “a cartridge that is designed to filter viruses and exosomes from the blood.” In turn, the patients were treated over a total of nine sessions, and both showed improvements in their condition.</p>\n<p>Moreover, the Hemopurifier is designated as a“Breakthrough Device”by the U.S. Food and Drug Administration (FDA) for treating metastatic cancer. Now, the tool is now closely being looked at by the FDA through an early feasibility study.</p>\n<p>Charles J. Fisher, Jr., CEO of Aethlon Medical, said this about the AEMD stock news.</p>\n<blockquote>\n “The COVID-19 pandemic has affected the world over, prompting the need for innovative treatment approaches. We believe that the Hemopurifier® is such an innovation, as it is the only known device that can filter out exosomes, which are thought to play a role in the severity of infectious diseases like COVID-19. … These two case studies indicate that the Hemopurifier® was successfully able to clear SARS-CoV-2 virus and associated exosomes from the blood stream, resulting in a potential benefit for one of the critical COVID-19 patients that were treated.”\n</blockquote>\n<p>AEMD stock was up&nbsp;388% as of Wednesday afternoon.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-10 07:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.\nAethlon Medical shared...</p>\n\n<a href=\"https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AEMD":"Aethlon Medical Inc"},"source_url":"https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168166668","content_text":"Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.\nAethlon Medical shared results last Thursday fortwo patients with Covid-19that were treated with the company’s Hemopurifier. According to the release, this is “a cartridge that is designed to filter viruses and exosomes from the blood.” In turn, the patients were treated over a total of nine sessions, and both showed improvements in their condition.\nMoreover, the Hemopurifier is designated as a“Breakthrough Device”by the U.S. Food and Drug Administration (FDA) for treating metastatic cancer. Now, the tool is now closely being looked at by the FDA through an early feasibility study.\nCharles J. Fisher, Jr., CEO of Aethlon Medical, said this about the AEMD stock news.\n\n “The COVID-19 pandemic has affected the world over, prompting the need for innovative treatment approaches. We believe that the Hemopurifier® is such an innovation, as it is the only known device that can filter out exosomes, which are thought to play a role in the severity of infectious diseases like COVID-19. … These two case studies indicate that the Hemopurifier® was successfully able to clear SARS-CoV-2 virus and associated exosomes from the blood stream, resulting in a potential benefit for one of the critical COVID-19 patients that were treated.”\n\nAEMD stock was up 388% as of Wednesday afternoon.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":189581329,"gmtCreate":1623281875461,"gmtModify":1704199857472,"author":{"id":"3579223722445124","authorId":"3579223722445124","name":"Nn9876543","avatar":"https://static.tigerbbs.com/f303d61037d0b19d1482129a96aaf20f","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3579223722445124","authorIdStr":"3579223722445124"},"htmlText":"Pls like n comment&nbsp;","listText":"Pls like n comment&nbsp;","text":"Pls like n comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/189581329","repostId":1168166668,"repostType":4,"repost":{"id":"1168166668","kind":"news","pubTimestamp":1623281394,"share":"https://ttm.financial/m/news/1168166668?lang=&edition=fundamental","pubTime":"2021-06-10 07:29","market":"us","language":"en","title":"AEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%","url":"https://stock-news.laohu8.com/highlight/detail?id=1168166668","media":"investorplace","summary":"Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged ","content":"<p>Shares of&nbsp;<b>Aethlon Medical</b>(NASDAQ:<b><u>AEMD</u></b>) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.</p>\n<p>Aethlon Medical shared results last Thursday fortwo patients with Covid-19that were treated with the company’s Hemopurifier. According to the release, this is “a cartridge that is designed to filter viruses and exosomes from the blood.” In turn, the patients were treated over a total of nine sessions, and both showed improvements in their condition.</p>\n<p>Moreover, the Hemopurifier is designated as a“Breakthrough Device”by the U.S. Food and Drug Administration (FDA) for treating metastatic cancer. Now, the tool is now closely being looked at by the FDA through an early feasibility study.</p>\n<p>Charles J. Fisher, Jr., CEO of Aethlon Medical, said this about the AEMD stock news.</p>\n<blockquote>\n “The COVID-19 pandemic has affected the world over, prompting the need for innovative treatment approaches. We believe that the Hemopurifier® is such an innovation, as it is the only known device that can filter out exosomes, which are thought to play a role in the severity of infectious diseases like COVID-19. … These two case studies indicate that the Hemopurifier® was successfully able to clear SARS-CoV-2 virus and associated exosomes from the blood stream, resulting in a potential benefit for one of the critical COVID-19 patients that were treated.”\n</blockquote>\n<p>AEMD stock was up&nbsp;388% as of Wednesday afternoon.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-10 07:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.\nAethlon Medical shared...</p>\n\n<a href=\"https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AEMD":"Aethlon Medical Inc"},"source_url":"https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168166668","content_text":"Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.\nAethlon Medical shared results last Thursday fortwo patients with Covid-19that were treated with the company’s Hemopurifier. According to the release, this is “a cartridge that is designed to filter viruses and exosomes from the blood.” In turn, the patients were treated over a total of nine sessions, and both showed improvements in their condition.\nMoreover, the Hemopurifier is designated as a“Breakthrough Device”by the U.S. Food and Drug Administration (FDA) for treating metastatic cancer. Now, the tool is now closely being looked at by the FDA through an early feasibility study.\nCharles J. Fisher, Jr., CEO of Aethlon Medical, said this about the AEMD stock news.\n\n “The COVID-19 pandemic has affected the world over, prompting the need for innovative treatment approaches. We believe that the Hemopurifier® is such an innovation, as it is the only known device that can filter out exosomes, which are thought to play a role in the severity of infectious diseases like COVID-19. … These two case studies indicate that the Hemopurifier® was successfully able to clear SARS-CoV-2 virus and associated exosomes from the blood stream, resulting in a potential benefit for one of the critical COVID-19 patients that were treated.”\n\nAEMD stock was up 388% as of Wednesday afternoon.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4656495,"gmtCreate":1623281891466,"gmtModify":1663228317425,"authorId":3557629001242050,"author":{"id":3557629001242050,"idStr":"3557629001242050","authorId":3557629001242050,"name":"kksuen","avatar":"https://static.tigerbbs.com/e1eb0ceb998a78cefb82c2f66d2addb1","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":189581329,"type":1,"supId":0,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"}],"langContent":"EN"},{"id":189580148,"gmtCreate":1623281773484,"gmtModify":1704199854020,"author":{"id":"3586375126532537","authorId":"3586375126532537","name":"SheldonK","avatar":"https://static.tigerbbs.com/b3ce0bf197f4f01a5fc9f5ba7451f0cc","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3586375126532537","authorIdStr":"3586375126532537"},"htmlText":"Nice！","listText":"Nice！","text":"Nice！","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/189580148","repostId":1168166668,"repostType":4,"repost":{"id":"1168166668","kind":"news","pubTimestamp":1623281394,"share":"https://ttm.financial/m/news/1168166668?lang=&edition=fundamental","pubTime":"2021-06-10 07:29","market":"us","language":"en","title":"AEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%","url":"https://stock-news.laohu8.com/highlight/detail?id=1168166668","media":"investorplace","summary":"Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged ","content":"<p>Shares of&nbsp;<b>Aethlon Medical</b>(NASDAQ:<b><u>AEMD</u></b>) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.</p>\n<p>Aethlon Medical shared results last Thursday fortwo patients with Covid-19that were treated with the company’s Hemopurifier. According to the release, this is “a cartridge that is designed to filter viruses and exosomes from the blood.” In turn, the patients were treated over a total of nine sessions, and both showed improvements in their condition.</p>\n<p>Moreover, the Hemopurifier is designated as a“Breakthrough Device”by the U.S. Food and Drug Administration (FDA) for treating metastatic cancer. Now, the tool is now closely being looked at by the FDA through an early feasibility study.</p>\n<p>Charles J. Fisher, Jr., CEO of Aethlon Medical, said this about the AEMD stock news.</p>\n<blockquote>\n “The COVID-19 pandemic has affected the world over, prompting the need for innovative treatment approaches. We believe that the Hemopurifier® is such an innovation, as it is the only known device that can filter out exosomes, which are thought to play a role in the severity of infectious diseases like COVID-19. … These two case studies indicate that the Hemopurifier® was successfully able to clear SARS-CoV-2 virus and associated exosomes from the blood stream, resulting in a potential benefit for one of the critical COVID-19 patients that were treated.”\n</blockquote>\n<p>AEMD stock was up&nbsp;388% as of Wednesday afternoon.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-10 07:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.\nAethlon Medical shared...</p>\n\n<a href=\"https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AEMD":"Aethlon Medical Inc"},"source_url":"https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168166668","content_text":"Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.\nAethlon Medical shared results last Thursday fortwo patients with Covid-19that were treated with the company’s Hemopurifier. According to the release, this is “a cartridge that is designed to filter viruses and exosomes from the blood.” In turn, the patients were treated over a total of nine sessions, and both showed improvements in their condition.\nMoreover, the Hemopurifier is designated as a“Breakthrough Device”by the U.S. Food and Drug Administration (FDA) for treating metastatic cancer. Now, the tool is now closely being looked at by the FDA through an early feasibility study.\nCharles J. Fisher, Jr., CEO of Aethlon Medical, said this about the AEMD stock news.\n\n “The COVID-19 pandemic has affected the world over, prompting the need for innovative treatment approaches. We believe that the Hemopurifier® is such an innovation, as it is the only known device that can filter out exosomes, which are thought to play a role in the severity of infectious diseases like COVID-19. … These two case studies indicate that the Hemopurifier® was successfully able to clear SARS-CoV-2 virus and associated exosomes from the blood stream, resulting in a potential benefit for one of the critical COVID-19 patients that were treated.”\n\nAEMD stock was up 388% as of Wednesday afternoon.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":189515424,"gmtCreate":1623281697168,"gmtModify":1704199850909,"author":{"id":"3571829669649843","authorId":"3571829669649843","name":"crisis","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3571829669649843","authorIdStr":"3571829669649843"},"htmlText":"Amazing&nbsp;","listText":"Amazing&nbsp;","text":"Amazing","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/189515424","repostId":1168166668,"repostType":4,"repost":{"id":"1168166668","kind":"news","pubTimestamp":1623281394,"share":"https://ttm.financial/m/news/1168166668?lang=&edition=fundamental","pubTime":"2021-06-10 07:29","market":"us","language":"en","title":"AEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%","url":"https://stock-news.laohu8.com/highlight/detail?id=1168166668","media":"investorplace","summary":"Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged ","content":"<p>Shares of&nbsp;<b>Aethlon Medical</b>(NASDAQ:<b><u>AEMD</u></b>) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.</p>\n<p>Aethlon Medical shared results last Thursday fortwo patients with Covid-19that were treated with the company’s Hemopurifier. According to the release, this is “a cartridge that is designed to filter viruses and exosomes from the blood.” In turn, the patients were treated over a total of nine sessions, and both showed improvements in their condition.</p>\n<p>Moreover, the Hemopurifier is designated as a“Breakthrough Device”by the U.S. Food and Drug Administration (FDA) for treating metastatic cancer. Now, the tool is now closely being looked at by the FDA through an early feasibility study.</p>\n<p>Charles J. Fisher, Jr., CEO of Aethlon Medical, said this about the AEMD stock news.</p>\n<blockquote>\n “The COVID-19 pandemic has affected the world over, prompting the need for innovative treatment approaches. We believe that the Hemopurifier® is such an innovation, as it is the only known device that can filter out exosomes, which are thought to play a role in the severity of infectious diseases like COVID-19. … These two case studies indicate that the Hemopurifier® was successfully able to clear SARS-CoV-2 virus and associated exosomes from the blood stream, resulting in a potential benefit for one of the critical COVID-19 patients that were treated.”\n</blockquote>\n<p>AEMD stock was up&nbsp;388% as of Wednesday afternoon.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 388%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-10 07:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.\nAethlon Medical shared...</p>\n\n<a href=\"https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AEMD":"Aethlon Medical Inc"},"source_url":"https://investorplace.com/2021/06/aemd-stock-the-historic-covid-19-news-sending-aethlon-medical-rocketing-350/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168166668","content_text":"Shares of Aethlon Medical(NASDAQ:AEMD) stock are blasting off on Wednesday after major news emerged from the company last week regarding the fight against the novel coronavirus.\nAethlon Medical shared results last Thursday fortwo patients with Covid-19that were treated with the company’s Hemopurifier. According to the release, this is “a cartridge that is designed to filter viruses and exosomes from the blood.” In turn, the patients were treated over a total of nine sessions, and both showed improvements in their condition.\nMoreover, the Hemopurifier is designated as a“Breakthrough Device”by the U.S. Food and Drug Administration (FDA) for treating metastatic cancer. Now, the tool is now closely being looked at by the FDA through an early feasibility study.\nCharles J. Fisher, Jr., CEO of Aethlon Medical, said this about the AEMD stock news.\n\n “The COVID-19 pandemic has affected the world over, prompting the need for innovative treatment approaches. We believe that the Hemopurifier® is such an innovation, as it is the only known device that can filter out exosomes, which are thought to play a role in the severity of infectious diseases like COVID-19. … These two case studies indicate that the Hemopurifier® was successfully able to clear SARS-CoV-2 virus and associated exosomes from the blood stream, resulting in a potential benefit for one of the critical COVID-19 patients that were treated.”\n\nAEMD stock was up 388% as of Wednesday afternoon.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4656459,"gmtCreate":1623281828592,"gmtModify":1663228316142,"authorId":3569839276167842,"author":{"id":3569839276167842,"idStr":"3569839276167842","authorId":3569839276167842,"name":"knn","avatar":"https://static.tigerbbs.com/f65a45bca8e472abcabb8f3a9ee2e9b0","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":189515424,"type":1,"supId":0,"prevId":0,"content":"comment my comment pl","text":"comment my comment pl","html":"comment my comment pl"}],"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":61,"commentSize":25,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}